This content is for educational purposes only and is not medical advice. Full disclaimer
Healing Beginner Friendly

BPC-157 + TB-500 Healing Stack

The gold standard peptide combination for tissue repair and recovery

BPC-157 TB-500

Stack Overview

The BPC-157 and TB-500 combination is the most widely used peptide stack for healing and recovery. These two compounds work through different but complementary mechanisms, making them synergistic when used together.

This stack is commonly used for:

  • Tendon and ligament injuries [3]
  • Muscle strains and tears
  • Joint pain and inflammation
  • Post-surgical recovery
  • Chronic injury rehabilitation
  • General tissue repair and regeneration

Why These Compounds Work Together

BPC-157 (Body Protection Compound-157)

BPC-157 is a 15-amino acid peptide derived from human gastric juice. Its mechanisms include:

  • Angiogenesis: Promotes new blood vessel formation [1]
  • Growth factor modulation: Upregulates VEGF and other growth factors [2]
  • Nitric oxide system: Interacts with NO pathways for healing
  • Local action: Most effective near the injection site

TB-500 (Thymosin Beta-4)

TB-500 is a 43-amino acid peptide found naturally in most cells. Its mechanisms include:

  • Cell migration: Promotes cell movement to injury sites [4]
  • Actin regulation: Controls cytoskeleton for cellular repair [7]
  • Anti-inflammatory: Reduces inflammation systemically
  • Systemic action: Works throughout the body [6]

Synergy Explained

Synergy Rating: Excellent

BPC-157 provides targeted local healing and blood vessel formation, while TB-500 works systemically to promote cell migration and reduce inflammation. Together, they address multiple healing pathways simultaneously.

How BPC-157 + TB-500 Work Together BPC-157 LOCAL ACTION New blood vessels Growth factor boost Nitric oxide repair Targets injury site TB-500 SYSTEMIC ACTION Cell migration Cytoskeleton repair Reduces inflammation Works whole body COMBINED RESULT Accelerated Healing +

Protocol

Beginner Protocol (8 weeks)

Compound Dose Frequency Timing
BPC-157 250-500 mcg Daily Near injury site, subcutaneous
TB-500 2-2.5 mg 2x weekly (loading)
1x weekly (maintenance)
Any site, subcutaneous

Loading vs Maintenance (TB-500)

  • Loading phase (weeks 1-4): 2-2.5mg twice per week
  • Maintenance phase (weeks 5-8+): 2mg once per week

BPC-157 does not require loading and is taken consistently throughout.

Injection Protocol

BPC-157: Inject subcutaneously as close to the injury site as practical. For systemic issues, abdomen is acceptable.

TB-500: Can be injected anywhere subcutaneously as it works systemically. Abdomen or thigh are common sites.

Reconstitution

Compound Vial Size BAC Water Concentration
BPC-157 5mg 2ml 2,500 mcg/ml (25 mcg per unit)
TB-500 5mg 2ml 2,500 mcg/ml (2.5mg = 100 units)

What to Expect

Healing Timeline — What to Expect 1 Week 1–2 Reduced inflammation and pain relief 2 Week 2–4 Improved mobility visible healing progress 3 Week 4–8 Significant tissue repair and functional improvement Individual response varies — some notice effects within days, others need several weeks

Timeline

  • Week 1-2: May notice reduced inflammation and pain
  • Week 2-4: Improved mobility, accelerated healing visible
  • Week 4-8: Significant tissue repair, functional improvement

Individual Response

Response varies based on injury severity, age, overall health, and other factors. Some users report noticeable effects within days, while others require several weeks.

Side Effects

Both compounds have favorable safety profiles in research. Reported effects include:

  • Injection site irritation (mild, temporary)
  • Fatigue (occasional, usually with TB-500)
  • Head rush (rare, usually subsides)
Research Status: Both BPC-157 and TB-500 are research compounds not approved for human use. Most studies are preclinical. Consult healthcare professionals before use.

Frequently Asked Questions

Can I take BPC-157 and TB-500 at the same time?

Yes, they can be injected in the same session, though typically in different sites. Some users draw both into the same syringe, though this is a matter of preference.

How long should I run this stack?

Most protocols run 4-12 weeks depending on injury severity. Some users cycle: 8 weeks on, 4 weeks off. For chronic issues, extended protocols are common.

Do I need to inject at the injury site?

For BPC-157, injecting near the injury appears to be more effective for localized issues. TB-500 works systemically regardless of injection site.

Can I take these orally?

BPC-157 is stable in stomach acid and can be taken orally, particularly for gut issues. TB-500 is not suitable for oral administration.

Related Stacks

References

  1. Hsieh MJ, et al. "Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation." J Mol Med. 2017;95(3):323-333. PubMed
  2. Sikiric P, et al. "BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing." Curr Pharm Des. 2018;24(18):1972-1989. PubMed
  3. Cerovecki T, et al. "Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing." J Physiol Pharmacol. 2010;61(Suppl 7):S191-S196. PubMed
  4. Malinda KM, et al. "Thymosin beta4 accelerates wound healing." J Invest Dermatol. 1999;113(3):364-368. PubMed
  5. Sosne G, et al. "Thymosin beta 4 promotes angiogenesis, wound healing, and hair follicle development." Ann N Y Acad Sci. 2004;1017:513-516. PubMed
  6. Smart N, et al. "Thymosin beta4 is a multi-functional regenerative peptide." Ann N Y Acad Sci. 2010;1194:199-204. PubMed
  7. Grant DS, et al. "The actin binding site on thymosin beta4 promotes angiogenesis." FASEB J. 2003;17(14):2103-2105. PubMed